mdx mouse
How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse
30
Early manifestation of alteration in cardiac function in dystrophin deficient mdx mouse using 3D CMR tagging
11
Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse
30
Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse
39
Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy
14
Whole-body clearing, staining and screening of calcium deposits in the mdx mouse model of Duchenne muscular dystrophy
12
IL 6 signaling blockade increases inflammation but does not affect muscle function in the mdx mouse
12
Applications of metabolomics and proteomics to the mdx mouse model of Duchenne muscular dystrophy: lessons from downstream of the transcriptome
11
The influence of sex hormones on cardiac and skeletal muscle function in the MDX mouse model of Duchenne Muscular Dystrophy
262
Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia
18
The Effect of Vitamin D Supplementation on Skeletal Muscle in the mdx Mouse Model of Duchenne Muscular Dystrophy
13
Rapamycin Ameliorates Dystrophic Phenotype in mdx Mouse Skeletal Muscle
8
Temporal changes in magnetic resonance imaging in the mdx mouse
5
The Female mdx Mouse: An Unexpected Vascular Story
13
Identification of qPCR reference genes suitable for normalizing gene expression in the mdx mouse model of Duchenne muscular dystrophy
28
Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation
26
Metabolic remodeling agents show beneficial effects in the dystrophin- deficient mdx mouse model
11
The influence of sex hormones on cardiac and skeletal muscle function in the MDX mouse model of Duchenne Muscular Dystrophy
18
Preclinical Studies in the mdx Mouse Model of Duchenne Muscular Dystrophy with the Histone Deacetylase Inhibitor Givinostat
9
Altered social behavior and ultrasonic communication in the dystrophin-deficient mdx mouse model of Duchenne muscular dystrophy
17